Spatial OMICS Industry Overview
The global spatial OMICS market size is expected to reach USD 484.22 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.00% from 2021 to 2028. The COVID-19 pandemic slowed down many industries worldwide. However, this market did not face the extensive negative impact of the pandemic.
Spatial OMICS Market Segmentation
Grand View Research has segmented the global spatial OMICS market on the basis of technology, product, workflow, sample type, end use, and region:
Based on the Technology Insights, the market is segmented into Spatial Transcriptomics, Spatial Genomics, Spatial Proteomics.
- The spatial transcriptomics segment dominated the market with a share of 63.56% in 2020. Continuous advancements in sequencing technologies have accelerated the transcriptomic study of single cells.
- The development of various in situ methods enhances the capabilities to explore spatial information in biological investigation.
- For example, a combination of in situ hybridization techniques with genetic tools helps explore the formation of gene expression gradients along with embryonic axes at different developmental stages. The gradient formation helps in understanding embryonic development and organ formation.
Based on the Product Insights, the market is segmented into Instruments, Consumables, Software.
- The consumables segment accounted for the largest share of 53.01% in 2020 owing to the high utilization rate and launch of novel products. For instance, in March 2021, Bruker launched new consumables for the chemical cross-linking of proteins (XL-MS).
- The launch of new instruments is directly associated with the development of the consumables. Therefore, this drives the instruments as well as the consumables segment.
- The growth of the software segment is attributed to the extensive use of tools for the analysis of single-cell omics data. For instance, in January 2021, researchers from the U.S. used GLUER (inteGrative anaLysis of mUlti-omics at single-cEll Resolution), a tool that integrated the imaging data with single-cell omics data.
Based on the Workflow Insights, the market is segmented into Sample Preparation, Instrumental Analysis, Data Analysis.
- The instrumental analysis segment dominated the market with a revenue share of 47.69% in 2020. The growth of the segment can be primarily attributed to substantial advancements being performed in instruments such as microscopy and mass spectrometry.
- It has several advantages such as high resolution, high speed, and high-throughput operations for profiling of protein, which are later used for analyzing complex biological samples.
- The data analysis segment is expected to witness lucrative growth over the forecast period owing to the increasing integration of advanced computational solutions for generating detailed spatial information for omics studies.
Based on the Sample Type Insights, the market is segmented into FFPE, Fresh Frozen.
- The formalin fixation and paraffin-embedding (FFPE) segment held the largest share of 57.26% in 2020. FFPE is considered a standard sample type that is most used for the preservation of human tissue for clinical diagnosis, and hence it holds a major share in the global market.
- In addition, FFPE specimens are found in abundance in clinical tissue banks, which contributes to the segment growth. However, they are incompatible with single-cell level transcriptome sequencing owing to RNA degradation and RNA damage during storage and extraction.
Based on the End-use Insights, the market is segmented into Academic Translational Research Institutes, Pharmaceutical and Biotechnology Companies.
- The academic and translational research institutes segment dominated the market with a revenue share of 89.60% in 2020. An increase in the adoption of spatial OMICS to translate real-time tissue responses to an external agent increases the technology’s adoption in translational research.
- This vital information may lead to the evolution of new and better ways to prevent diseases. For instance, single-cell transcriptomics is found to be useful for neuroscientists to understand cell types forming the brain.
- Spatially resolved transcriptomics methods play a fundamental role to fill this gap by localizing molecularly defined tissue or cell types, with simultaneous detection of activity, morphology, and connectivity.
Spatial OMICS Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa (MEA)
Key Companies Profile Market Share Insights
10x Genomics is a leading player in the global market. The company has set off the trend for spatial transcriptomics with the launch of the Visium Spatial Gene Expression platform.
Some prominent players in the global spatial OMICS market include
- 10x Genomics
- Dovetail Genomics
- S2 Genomics, Inc.
- NanoString Technologies, Inc.
- Seven Bridges Genomics
- PerkinElmer, Inc.
- Bio-Techne
- Danaher Corporation
- IonPath, Inc.
- Millennium Science Pty Ltd.
- Akoya Biosciences, Inc.
- Fluidigm Corporation
- Diagenode Diagnostics
- Biognosys AG
- Rebus Biosystems
- Ultivue, Inc.
- Vizgen Corp.
- BioSpyder Technologies
- Bruker
- Brooks Automation, Inc.
Order a free sample PDF of the Spatial OMICS Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
